STOCK TITAN

Marsh & McLennan (NYSE: MRSH) director sells 12000 shares at $175.6500

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Marsh & McLennan Companies director Lloyd M. Yates sold 12000 shares of Common Stock on July 23, 2026 at $175.6500 per share in an open-market or private transaction. After this sale, he directly owned 12000.7500 shares, and the trade was not made under a Rule 10b5-1 plan.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Yates Lloyd M
Role Director
Sold 12,000 shs ($2.11M)
Type Security Shares Price Value
Sale Common Stock 12,000 $175.65 $2.11M
Holdings After Transaction: Common Stock — 12,000.75 shares (Direct)
Shares sold 12000 shares Common Stock sold by director Lloyd M. Yates on 2026-07-23
Sale price per share $175.6500 per share Per-share price for the Common Stock sale on 2026-07-23
Shares owned after sale 12000.7500 shares Direct Marsh & McLennan Common Stock holdings after the reported transaction
Net shares sold 12000 shares Net sell shares reported in the transaction summary
Common Stock financial
"Security title for the reported transaction is "Common Stock"."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
open market financial
"Transaction code description notes a sale in "open market"."
An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.
private transaction financial
"Code description allows for a sale in a "private transaction"."
A private transaction is the sale or transfer of securities, assets, or ownership stakes carried out directly between a small number of parties rather than on a public exchange. For investors it matters because these deals are less visible and often less liquid than public trades, so pricing can be harder to verify, the investment can be harder to sell quickly, and buyers or sellers may gain strategic advantages not available in open markets — like negotiated terms similar to a private garage sale versus a crowded marketplace.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Marsh & McLennan (MRSH) report for Lloyd M. Yates?

Marsh & McLennan reported that director Lloyd M. Yates sold 12000 shares of Common Stock. The sale occurred on July 23, 2026 and was coded as a sale in an open-market or private transaction, reflecting a net disposition of shares.

How many Marsh & McLennan (MRSH) shares did Lloyd M. Yates sell and at what price?

Lloyd M. Yates sold 12000 Marsh & McLennan Common Stock shares at $175.6500 per share. The transaction was recorded as a non-derivative sale on July 23, 2026, with the price reported on a per-share basis.

What is Lloyd M. Yates’s remaining Marsh & McLennan (MRSH) ownership after this sale?

After the reported sale, Lloyd M. Yates directly owned 12000.7500 Marsh & McLennan shares. This figure reflects his direct Common Stock holdings immediately following the July 23, 2026 open-market or private transaction.

Was Lloyd M. Yates’s Marsh & McLennan (MRSH) share sale under a Rule 10b5-1 plan?

The transaction was not reported as being under a Rule 10b5-1 trading plan. The Rule 10b5-1 affirmation box was not checked, indicating the sale was not designated as executed pursuant to a pre-arranged trading plan.

What type of security did Lloyd M. Yates trade in this Marsh & McLennan (MRSH) filing?

The transaction involved Marsh & McLennan Common Stock as a non-derivative security. The Form 4 entry specifies “Common Stock” as the security title, with all reported shares sold directly rather than through derivative instruments.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Yates Lloyd M

(Last)(First)(Middle)
C/O MARSH & MCLENNAN COMPANIES, INC.
1166 AVENUE OF THE AMERICAS

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MARSH & MCLENNAN COMPANIES, INC. [ MRSH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/23/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/23/2026S12,000D$175.6512,000.75D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Tessa Patti, Attorney-in-fact07/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)